Several studies have shown that the ability of NAMPT to generate NAD+ is important in promoting glioma, and other cancers, by increasing the activity of NAD+-dependent enzymes (Gujar et al, 2016; Kennedy et al, 2016; Lucena-Cacace et al, 2017, 2018). Here, NAMPT is linked to cancer.